{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:07:59Z","timestamp":1789729679433,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,7,16]],"date-time":"2010-07-16T00:00:00Z","timestamp":1279238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2010,7,16]],"date-time":"2010-07-16T00:00:00Z","timestamp":1279238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>The present study objective was to evaluate the incidence of methotrexate (MTX)-specific liver lesions from the analysis of a liver biopsy of inflammatory arthritis patients with elevated liver enzymes.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>A case-control study was performed with 1,571 arthritis patients on long-term low-dose MTX therapy. Results of liver biopsy were analyzed in 41 patients with elevated liver enzymes. The expression of autoimmune markers was also assessed. This population was compared with 41 disease control subjects obtained from the same database, also on MTX but without elevated liver enzymes, matched for age, sex and rheumatic disease.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Compared with the disease controls, patients with liver biopsy showed lower disease duration and lower MTX exposure, weekly and cumulative doses, reflecting shorter treatment duration due to liver abnormalities. Liver biopsies showed 17 autoimmune hepatitis-like (AIH-like) lesions, 13 nonalcoholic steatohepatitis-like lesions, seven limited liver lesions, and two primary biliary cirrhoses. However, MTX-specific lesions with dystrophic nuclei in hepatocytes were seen in only two cases. Liver biopsy lesions were associated with autoimmune markers (<jats:italic>P<\/jats:italic> = 0.007); notably, AIH-like lesions were associated with rheumatoid arthritis and with the presence of the HLA-DR shared epitope.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>MTX-specific liver lesions are rarely observed in arthritis patients under long-term MTX therapy and elevated liver enzymes.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar3085","type":"journal-article","created":{"date-parts":[[2010,7,16]],"date-time":"2010-07-16T18:13:51Z","timestamp":1279304031000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Rare incidence of methotrexate-specific lesions in liver biopsy of patients with arthritis and elevated liver enzymes"],"prefix":"10.1186","volume":"12","author":[{"given":"Emilie","family":"Quintin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Scoazec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Marotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Miossec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,16]]},"reference":[{"key":"2920_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s000110050307","volume":"47","author":"MJ Ahern","year":"1998","unstructured":"Ahern MJ, Smith MD, Roberts-Thomson PJ: Methotrexate hepatotoxicity: what is the evidence?. Inflamm Res. 1998, 47: 148-151. 10.1007\/s000110050307.","journal-title":"Inflamm Res"},{"key":"2920_CR2","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1056\/NEJM198503283121303","volume":"312","author":"ME Weinblatt","year":"1985","unstructured":"Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, Glass DN, Trentham DE: Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med. 1985, 312: 818-822. 10.1056\/NEJM198503283121303.","journal-title":"N Engl J Med"},{"key":"2920_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/ar419","volume":"4","author":"ES Chan","year":"2002","unstructured":"Chan ES, Cronstein BN: Molecular action of methotrexate in inflammatory diseases. Arthritis Res. 2002, 4: 266-273. 10.1186\/ar419.","journal-title":"Arthritis Res"},{"key":"2920_CR4","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1172\/JCI116884","volume":"92","author":"BN Cronstein","year":"1993","unstructured":"Cronstein BN, Naime D, Ostad E: The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest. 1993, 92: 2675-2682. 10.1172\/JCI116884.","journal-title":"J Clin Invest"},{"key":"2920_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/art.1780370304","volume":"37","author":"JM Kremer","year":"1994","unstructured":"Kremer JM, Alarcon GS, Lightfoot RW, Willkens RF, Furst DE, Williams HJ, Dent PB, Weinblatt ME: Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum. 1994, 37: 316-328. 10.1002\/art.1780370304.","journal-title":"Arthritis Rheum"},{"key":"2920_CR6","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1136\/ard.2008.093690","volume":"68","author":"C Salliot","year":"2009","unstructured":"Salliot C, van der Heijde D: Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis. 2009, 68: 1100-1104. 10.1136\/ard.2008.093690.","journal-title":"Ann Rheum Dis"},{"key":"2920_CR7","first-page":"1017","volume":"27","author":"K Visser","year":"2009","unstructured":"Visser K, van der Heijde DM: Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature. Clin Exp Rheumatol. 2009, 27: 1017-1025.","journal-title":"Clin Exp Rheumatol"},{"key":"2920_CR8","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1136\/ard.2008.094474","volume":"68","author":"K Visser","year":"2009","unstructured":"Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J, Bombardier C, Carmona L, van der Heijde D, Bijlsma JW, Boumpas DT, Canhao H, Edwards CJ, Hamuryudan V, Kvien TK, Leeb BF, Martin-Mola EM, Mielants H, Muller-Ladner U, Murphy G, Ostergaard M, Pereira IA, Ramos-Remus C, Valentini G, Zochling J, Dougados M: Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis. 2009, 68: 1086-1093. 10.1136\/ard.2008.094474.","journal-title":"Ann Rheum Dis"},{"key":"2920_CR9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nrrheum.2009.41","volume":"5","author":"JM Kremer","year":"2009","unstructured":"Kremer JM: Therapy: methotrexate guidelines: compromise to reach consensus. Nat Rev Rheumatol. 2009, 5: 186-187. 10.1038\/nrrheum.2009.41.","journal-title":"Nat Rev Rheumatol"},{"key":"2920_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1034\/j.1600-0676.2000.020005366.x","volume":"20","author":"T Matsumoto","year":"2000","unstructured":"Matsumoto T, Kobayashi S, Shimizu H, Nakajima M, Watanabe S, Kitami N, Sato N, Abe H, Aoki Y, Hoshi T, Hashimoto H: The liver in collagen diseases: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver. Liver. 2000, 20: 366-373. 10.1034\/j.1600-0676.2000.020005366.x.","journal-title":"Liver"},{"key":"2920_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1136\/ard.2002.001826","volume":"63","author":"S Abraham","year":"2004","unstructured":"Abraham S, Begum S, Isenberg D: Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis. 2004, 63: 123-129. 10.1136\/ard.2002.001826.","journal-title":"Ann Rheum Dis"},{"key":"2920_CR12","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/art.1780311202","volume":"31","author":"DJ Bjorkman","year":"1988","unstructured":"Bjorkman DJ, Hammond EH, Lee RG, Clegg DO, Tolman KG: Hepatic ultrastructure after methotrexate therapy for rheumatoid arthritis. Arthritis Rheum. 1988, 31: 1465-1472. 10.1002\/art.1780311202.","journal-title":"Arthritis Rheum"},{"key":"2920_CR13","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/bmj.1.5801.654","volume":"1","author":"MG Dahl","year":"1972","unstructured":"Dahl MG, Gregory MM, Scheuer PJ: Methotrexate hepatotoxicity in psoriasis - comparison of different dose regimens. Br Med J. 1972, 1: 654-656. 10.1136\/bmj.1.5801.654.","journal-title":"Br Med J"},{"key":"2920_CR14","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/art.1780380904","volume":"38","author":"JM Kremer","year":"1995","unstructured":"Kremer JM, Kaye GI, Kaye NW, Ishak KG, Axiotis CA: Light and electron microscopic analysis of sequential liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy. Followup over long treatment intervals and correlation with clinical and laboratory variables. Arthritis Rheum. 1995, 38: 1194-1203. 10.1002\/art.1780380904.","journal-title":"Arthritis Rheum"},{"key":"2920_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1365-2133.1980.tb06553.x","volume":"102","author":"H Zachariae","year":"1980","unstructured":"Zachariae H, Kragballe K, Sogaard H: Methotrexate induced liver cirrhosis. Studies including serial liver biopsies during continued treatment. Br J Dermatol. 1980, 102: 407-412. 10.1111\/j.1365-2133.1980.tb06553.x.","journal-title":"Br J Dermatol"},{"key":"2920_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1001\/archderm.1969.01610290007002","volume":"100","author":"SA Muller","year":"1969","unstructured":"Muller SA, Farrow GM, Martalock DL: Cirrhosis caused by methotrexate in the treatment of psoriasis. Arch Dermatol. 1969, 100: 523-530. 10.1001\/archderm.100.5.523.","journal-title":"Arch Dermatol"},{"key":"2920_CR17","first-page":"511","volume":"85","author":"A Nyfors","year":"1977","unstructured":"Nyfors A: Liver biopsies from psoriatics related to methotrexate therapy. 3. Findings in post-methotrexate liver biopsies from 160 psoriatics. Acta Pathol Microbiol Scand [A]. 1977, 85: 511-518.","journal-title":"Acta Pathol Microbiol Scand [A]"},{"key":"2920_CR18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0002-9343(05)80060-9","volume":"90","author":"QE Whiting-O'Keefe","year":"1991","unstructured":"Whiting-O'Keefe QE, Fye KH, Sack KD: Methotrexate and histologic hepatic abnormalities: a meta-analysis. Am J Med. 1991, 90: 711-716.","journal-title":"Am J Med"},{"key":"2920_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JE, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. 10.1002\/art.1780310302.","journal-title":"Arthritis Rheum"},{"key":"2920_CR20","first-page":"85","volume":"142","author":"B Amor","year":"1991","unstructured":"Amor B, Dougados M, Listrat V, Menkes CJ, Dubost JJ, Roux H, Benhamou C, Blotman F, Pattin S, Paolaggi JB, et al: Evaluation of the Amor criteria for spondylarthropathies and European Spondylarthropathy Study Group (ESSG). A cross-sectional analysis of 2,228 patients. Ann Med Interne (Paris). 1991, 142: 85-89.","journal-title":"Ann Med Interne (Paris)"},{"key":"2920_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/ard.55.2.116","volume":"55","author":"C Vitali","year":"1996","unstructured":"Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY, Kater L, Konttinen YT, Manthorpe R, Meyer O, Mosca M, Ostuni P, Pellerito RA, Pennec Y, Porter SR, Richards A, Sauvezie B, Schiodt M, Sciuto M, Shoenfeld Y, Skopouli FN, Smolen JS, Soromenho F, Tishler M, Wattiaux MJ: Assessment of the European classification criteria for Sjogren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren's Syndrome. Ann Rheum Dis. 1996, 55: 116-121. 10.1136\/ard.55.2.116.","journal-title":"Ann Rheum Dis"},{"key":"2920_CR22","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S1089-3261(03)00101-6","volume":"7","author":"U Leuschner","year":"2003","unstructured":"Leuschner U: Primary biliary cirrhosis presentation and diagnosis. Clin Liver Dis. 2003, 7: 741-758. 10.1016\/S1089-3261(03)00101-6.","journal-title":"Clin Liver Dis"},{"key":"2920_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1053\/jhep.2002.34944","volume":"36","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ, Freese DK: Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002, 36: 479-497. 10.1053\/jhep.2002.34944.","journal-title":"Hepatology"},{"key":"2920_CR24","first-page":"1590","volume":"29","author":"JM Kremer","year":"2002","unstructured":"Kremer JM: Not yet time to change the guidelines for monitoring methotrexate liver toxicity: they have served us well. J Rheumatol. 2002, 29: 1590-1592.","journal-title":"J Rheumatol"},{"key":"2920_CR25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/archinte.1973.03650090071013","volume":"132","author":"H Tobias","year":"1973","unstructured":"Tobias H, Auerbach R: Hepatotoxicity of long-term methotrexate therapy for psoriasis. Arch Intern Med. 1973, 132: 391-396. 10.1001\/archinte.132.3.391.","journal-title":"Arch Intern Med"},{"key":"2920_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/rheumatology\/36.2.210","volume":"36","author":"EM Ruderman","year":"1997","unstructured":"Ruderman EM, Crawford JM, Maier A, Liu JJ, Gravallese EM, Weinblatt ME: Histologic liver abnormalities in an autopsy series of patients with rheumatoid arthritis. Br J Rheumatol. 1997, 36: 210-213. 10.1093\/rheumatology\/36.2.210.","journal-title":"Br J Rheumatol"},{"key":"2920_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/rheumatology\/39.1.50","volume":"39","author":"S Richard","year":"2000","unstructured":"Richard S, Guerret S, Gerard F, Tebib JG, Vignon E: Hepatic fibrosis in rheumatoid arthritis patients treated with methotrexate: application of a new semi-quantitative scoring system. Rheumatology (Oxford). 2000, 39: 50-54. 10.1093\/rheumatology\/39.1.50.","journal-title":"Rheumatology (Oxford)"},{"key":"2920_CR28","first-page":"2092","volume":"29","author":"NH Fathi","year":"2002","unstructured":"Fathi NH, Mitros F, Hoffman J, Straniero N, Labreque D, Koehnke R, Furst DE: Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritis. J Rheumatol. 2002, 29: 2092-2098.","journal-title":"J Rheumatol"},{"key":"2920_CR29","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1046\/j.1440-1746.2001.02644.x","volume":"16","author":"G Langman","year":"2001","unstructured":"Langman G, Hall PM, Todd G: Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury. J Gastroenterol Hepatol. 2001, 16: 1395-1401. 10.1046\/j.1440-1746.2001.02644.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"2920_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1046\/j.1365-2036.2004.01819.x","volume":"19","author":"GP Aithal","year":"2004","unstructured":"Aithal GP, Haugk B, Das S, Card T, Burt AD, Record CO: Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?. Aliment Pharmacol Ther. 2004, 19: 391-399. 10.1046\/j.1365-2036.2004.01819.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"2920_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1478-3231.2007.01489.x","volume":"27","author":"MA Berends","year":"2007","unstructured":"Berends MA, Snoek J, de Jong EM, Van Krieken JH, de Knegt RJ, van Oijen MG, van de Kerkhof PC, Drenth JP: Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis. Liver Int. 2007, 27: 639-645. 10.1111\/j.1478-3231.2007.01489.x.","journal-title":"Liver Int"},{"key":"2920_CR32","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/rheumatology\/keh668","volume":"44","author":"MJ Nissen","year":"2005","unstructured":"Nissen MJ, Fontanges E, Allam Y, Zoulim F, Trepo C, Miossec P: Rheumatological manifestations of hepatitis C: incidence in a rheumatology and non-rheumatology setting and the effect of methotrexate and interferon. Rheumatology (Oxford). 2005, 44: 1016-1020. 10.1093\/rheumatology\/keh668.","journal-title":"Rheumatology (Oxford)"},{"key":"2920_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/rheumatology\/kel191","volume":"46","author":"H Marotte","year":"2007","unstructured":"Marotte H, Fontanges E, Bailly F, Zoulim F, Trepo C, Miossec P: Etanercept treatment for three months is safe in patients with rheumatological manifestations associated with hepatitis C virus. Rheumatology (Oxford). 2007, 46: 97-99. 10.1093\/rheumatology\/kel191.","journal-title":"Rheumatology (Oxford)"},{"key":"2920_CR34","volume-title":"Hepatology","author":"RJ Fontana","year":"2010","unstructured":"Fontana RJ, Seeff LB, Andrade RJ, Bjornsson E, Day CP, Serrano J, Hoofnagle JH: Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology. 2010,"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3085.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar3085\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3085.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:57:21Z","timestamp":1728385041000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar3085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,16]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2010,8]]}},"alternative-id":["2920"],"URL":"https:\/\/doi.org\/10.1186\/ar3085","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,16]]},"assertion":[{"value":"26 October 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R143"}}